VDC vs XBI
Vanguard Consumer Staples ETF vs SPDR S&P Biotech ETF
- • VDC has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VDC pays a higher dividend yield (2.13%).
Side-by-side metrics
| Metric | VDC | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.13% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $9.19B | $10.73B |
YTD return | 9.49% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.54 | 1.10 |
P/E ratio | 25.13 | — |
Last price | $226.06 | $164.01 |
Inception | — | — |
Issuer | Vanguard | State Street |
VDC top holdings
| WMT | Walmart Inc | 14.46% |
| COST | Costco Wholesale Corp | 11.81% |
| PG | Procter & Gamble Co | 8.67% |
| KO | Coca-Cola Co | 7.89% |
| PEP | PepsiCo Inc | 4.51% |
| PM | Philip Morris International Inc | 4.35% |
| MO | Altria Group Inc | 3.89% |
| MDLZ | Mondelez International Inc Class A | 2.68% |
| CL | Colgate-Palmolive Co | 2.37% |
| MNST | Monster Beverage Corp | 2.23% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About VDC
VDC (Vanguard Consumer Staples ETF) is US consumer staples sector stocks. Managed by Vanguard, the fund carries $9.2B in assets under management, an expense ratio of 0.09%, a dividend yield of 2.13%. Its largest holding is Walmart Inc (WMT), which represents 14.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.6%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.